Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fredrick Wigley

Showing results (11-20 of 28) with videos related to

Pageof 3
Sort By:
Arthritis and Rheumatism|April 1, 2009
Lack of detection of agonist activity by antibodies to platelet-derived growth factor receptor alpha in a subset of normal and systemic sclerosis patient seraNick Loizos, Leah Lariccia, Jami Weiner, et al.
Clinical and Experimental Rheumatology|January 27, 2022
Troponin elevation independently associates with mortality in systemic sclerosisJulie J Paik, Deborah Y Choi, Monica Mukherjee, et al.
Rheumatology (Oxford, England)|February 4, 2014
A double-blind, randomized, placebo-controlled crossover trial of the α2C-adrenoceptor antagonist ORM-12741 for prevention of cold-induced vasospasm in patients with systemic sclerosisAriane L Herrick, Andrea K Murray, Angela Ruck, et al.
The Lancet. Rheumatology|May 3, 2022
Effect of mycophenolate mofetil dose on antibody response following initial SARS-CoV-2 vaccination in patients with systemic sclerosisRachel Wallwork, Caoilfhionn M Connolly, Matthew Shneyderman, et al.
Journal of the American Society of Echocardiography : Official Publication of the American Society of Echocardiography|October 15, 2022
Stress Echocardiographic Prediction of Emerging Pulmonary Vascular Disease in Systemic SclerosisJim Lu, Vivek Jani, Valentina Mercurio, et al.
Arthritis and Rheumatism|September 2, 2006
Clinical differences between idiopathic and scleroderma-related pulmonary hypertensionMicah R Fisher, Stephen C Mathai, Hunter C Champion, et al.
Arthritis Research & Therapy|April 20, 2013
Open label study of escalating doses of oral treprostinil diethanolamine in patients with systemic sclerosis and digital ischemia: pharmacokinetics and correlation with digital perfusionAmi A Shah, Elena Schiopu, Laura K Hummers, et al.
Medicine|March 2, 2011
High-dose cyclophosphamide without stem cell rescue in 207 patients with aplastic anemia and other autoimmune diseasesAmy E DeZern, Michelle Petri, Daniel B Drachman, et al.
Rheumatology (Oxford, England)|June 7, 2019
Performance of the Patient-Reported Outcomes Measurement Information System-29 in scleroderma: a Scleroderma Patient-centered Intervention Network Cohort StudyLinda Kwakkenbos, Brett D Thombs, Dinesh Khanna, et al.
Rheumatology (Oxford, England)|April 22, 2017
Performance of the Patient-Reported Outcomes Measurement Information System-29 in scleroderma: a Scleroderma Patient-centered Intervention Network Cohort StudyLinda Kwakkenbos, Brett D Thombs, Dinesh Khanna, et al.
Pageof 3

Showing results (11-20 of 28) with videos related to

Sort By:
Pageof 3
Arthritis and Rheumatism|April 1, 2009
Lack of detection of agonist activity by antibodies to platelet-derived growth factor receptor alpha in a subset of normal and systemic sclerosis patient seraNick Loizos, Leah Lariccia, Jami Weiner, et al.
Clinical and Experimental Rheumatology|January 27, 2022
Troponin elevation independently associates with mortality in systemic sclerosisJulie J Paik, Deborah Y Choi, Monica Mukherjee, et al.
Rheumatology (Oxford, England)|February 4, 2014
A double-blind, randomized, placebo-controlled crossover trial of the α2C-adrenoceptor antagonist ORM-12741 for prevention of cold-induced vasospasm in patients with systemic sclerosisAriane L Herrick, Andrea K Murray, Angela Ruck, et al.
The Lancet. Rheumatology|May 3, 2022
Effect of mycophenolate mofetil dose on antibody response following initial SARS-CoV-2 vaccination in patients with systemic sclerosisRachel Wallwork, Caoilfhionn M Connolly, Matthew Shneyderman, et al.
Journal of the American Society of Echocardiography : Official Publication of the American Society of Echocardiography|October 15, 2022
Stress Echocardiographic Prediction of Emerging Pulmonary Vascular Disease in Systemic SclerosisJim Lu, Vivek Jani, Valentina Mercurio, et al.
Arthritis and Rheumatism|September 2, 2006
Clinical differences between idiopathic and scleroderma-related pulmonary hypertensionMicah R Fisher, Stephen C Mathai, Hunter C Champion, et al.
Arthritis Research & Therapy|April 20, 2013
Open label study of escalating doses of oral treprostinil diethanolamine in patients with systemic sclerosis and digital ischemia: pharmacokinetics and correlation with digital perfusionAmi A Shah, Elena Schiopu, Laura K Hummers, et al.
Medicine|March 2, 2011
High-dose cyclophosphamide without stem cell rescue in 207 patients with aplastic anemia and other autoimmune diseasesAmy E DeZern, Michelle Petri, Daniel B Drachman, et al.
Rheumatology (Oxford, England)|June 7, 2019
Performance of the Patient-Reported Outcomes Measurement Information System-29 in scleroderma: a Scleroderma Patient-centered Intervention Network Cohort StudyLinda Kwakkenbos, Brett D Thombs, Dinesh Khanna, et al.
Rheumatology (Oxford, England)|April 22, 2017
Performance of the Patient-Reported Outcomes Measurement Information System-29 in scleroderma: a Scleroderma Patient-centered Intervention Network Cohort StudyLinda Kwakkenbos, Brett D Thombs, Dinesh Khanna, et al.
Pageof 3